Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vernant

Showing results (271-280 of 307) with videos related to

Pageof 31
Sort By:
Transplantation|September 30, 1998
Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBcN Dhédin, C Douvin, M Kuentz, et al.
Bone Marrow Transplantation|January 1, 1996
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT)F Frassoni, M Labopin, E Gluckman, et al.
Leukemia|October 12, 1999
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patientsR Bouabdallah, F Lefrère, C Rose, et al.
Bone Marrow Transplantation|January 7, 1998
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)E Deconinck, J Y Cahn, N Milpied, et al.
British Journal of Haematology|November 25, 2000
Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow TransplantationP Guardiola, M Kuentz, F Garban, et al.
Bone Marrow Transplantation|July 12, 2005
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trialD Valteau-Couanet, C Faucher, A Aupérin, et al.
Bone Marrow Transplantation|May 1, 1997
Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) StudyO Ringdén, M Labopin, E Gluckman, et al.
Lancet (London, England)|November 3, 1998
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Gratwohl, J Hermans, J M Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disordersV Leblond, N Dhedin, M F Mamzer Bruneel, et al.
Leukemia|September 26, 1997
Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients. French Group for Treatment of Adult Acute Lymphoblastic LeukemiaA Delannoy, C Sebban, P Cony-Makhoul, et al.
Pageof 31

Showing results (271-280 of 307) with videos related to

Sort By:
Pageof 31
Transplantation|September 30, 1998
Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBcN Dhédin, C Douvin, M Kuentz, et al.
Bone Marrow Transplantation|January 1, 1996
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT)F Frassoni, M Labopin, E Gluckman, et al.
Leukemia|October 12, 1999
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patientsR Bouabdallah, F Lefrère, C Rose, et al.
Bone Marrow Transplantation|January 7, 1998
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)E Deconinck, J Y Cahn, N Milpied, et al.
British Journal of Haematology|November 25, 2000
Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow TransplantationP Guardiola, M Kuentz, F Garban, et al.
Bone Marrow Transplantation|July 12, 2005
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trialD Valteau-Couanet, C Faucher, A Aupérin, et al.
Bone Marrow Transplantation|May 1, 1997
Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) StudyO Ringdén, M Labopin, E Gluckman, et al.
Lancet (London, England)|November 3, 1998
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Gratwohl, J Hermans, J M Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disordersV Leblond, N Dhedin, M F Mamzer Bruneel, et al.
Leukemia|September 26, 1997
Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients. French Group for Treatment of Adult Acute Lymphoblastic LeukemiaA Delannoy, C Sebban, P Cony-Makhoul, et al.
Pageof 31